Thoracic Surgery in Non-Small Cell Lung Cancer with Epidermal Growth Factor Receptor Mutant After Tyrosine Kinase Inhibitor Therapy

被引：0

作者：

Hsiao, C. ^{[1
]}

Kuo, S. ^{[2
,3
]}

Chen, K. ^{[4
]}

Chen, J. ^{[2
,3
]}

机构：

[1] Cheng Hsin Gen Hosp, Surg, Taipei, Taiwan

[2] Natl Taiwan Univ Hosp, Surg, Taipei, Taiwan

[3] Natl Taiwan Univ, Coll Med, Taipei, Taiwan

[4] Natl Taiwan Univ, Dept Surg, Taipei, Taiwan

来源：

JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期

关键词：

Tyrosine kinase inhibitors; Thoracic Surgery; non-small cell lung cancer;

D O I：

10.1016/j.jtho.2018.08.592

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.01-36

引用

页码：S474 / S474

页数：1

共 50 条

[31] Overcoming resistance to third-generation epidermal growth factor receptor tyrosine kinase inhibitor in non-small cell lung cancer
Noda-Narita, Shoko
Kanda, Shintaro
TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S187 - S190
[32] Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer
Keam, Bhumsuk
Kim, Dong-Wan
Park, Jin Hyun
Lee, Jeong-Ok
Kim, Tae Min
Lee, Se-Hoon
Chung, Doo Hyun
Heo, Dae Seog
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2014, 19 (04) : 594 - 600
[33] Rare and complex mutations of epidermal growth factor receptor, and efficacy of tyrosine kinase inhibitor in patients with non-small cell lung cancer
Bhumsuk Keam
Dong-Wan Kim
Jin Hyun Park
Jeong-Ok Lee
Tae Min Kim
Se-Hoon Lee
Doo Hyun Chung
Dae Seog Heo
International Journal of Clinical Oncology, 2014, 19 : 594 - 600
[34] Personalized medicine for non-small cell lung cancer patients treated with epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib
Hamada, Akinobu
Sasaki, Ji-ichiro
Saeki, Sho
Iwamoto, Norihiro
Inaba, Megumi
Ushijima, Sunao
Urata, Maki
Kishi, Hiroto
Fujii, Shinji
Semba, Hiroshi
Kai, Yuki
Saito, Hideyuki
CANCER RESEARCH, 2010, 70
[35] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Treatment Response in Advanced Non-Small Cell Lung Cancer With Uncommon Mutations
Kanazu, Masaki
Naoki, Yoko
Shiroyama, Takayuki
Tamiya, Motohiro
Tamiya, Akihiro
Omachi, Naoki
Okishio, Kyoichi
Suzuki, Hidekazu
Okamoto, Norio
Morishita, Naoko
Hirashima, Tomonori
Atagi, Shinji
JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S318 - S318
[36] Sequential Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor-Induced Radical Surgery in Oligometastatic Non-small Cell Lung Cancer: A Case Report
Wang, Huaiyu
Fan, Zaiwen
Yang, Xiaoming
Wu, Qing
Jiang, Suxin
Zhu, Jingna
Liu, Jie
Zhou, Chuanhong
Liu, Yinghui
You, Xia
Han, Yong
ONCOLOGIST, 2024, 29 (06): : 543 - 545
[37] Histological transformation from non-small cell to small cell lung carcinoma after treatment with epidermal growth factor receptor-tyrosine kinase inhibitor
Kim, Woo-Jin
Kim, Sunmin
Choi, Hayoung
Chang, Jinsun
Shin, Hong-Joon
Park, Cheol-Kyu
Oh, In-Jae
Kim, Kyu-Sik
Kim, Young-Chul
Choi, Yoo-Duk
THORACIC CANCER, 2015, 6 (06) : 800 - 804
[38] Effect of epidermal growth factor receptor tyrosine kinase domain mutations on the outcome of patients with non-small cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors
Jaenne, Pasi A.
Johnson, Bruce E.
CLINICAL CANCER RESEARCH, 2006, 12 (14) : 4416S - 4420S
[39] Somatic mutations of the tyrosine kinase domain of epidermal growth factor receptor and tyrosine kinase inhibitor response to TKIs in non-small cell lung cancer: An analytical database
Murray, Samuel
Dahabreh, Issa J.
Linardou, Helena
Manoloukos, Menelaos
Bafaloukos, Dimitrios
Kosmidis, Paris
JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (08) : 832 - 839
[40] Rare mutations of epidermal growth factor receptor in epidermal growth factor receptor-tyrosine kinase inhibitor-naive non-small cell lung carcinoma and the response to erlotinib therapy
Sari, Murat
Aydiner, Adnan
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2020, 16 (01) : 132 - 138

← 1 2 3 4 5 →